China is preparing the ground for “vaccine diplomacy”

Sep 13, 2020 – 13 07: 16

2020-09-13 07:16

Chiny przygotowują grunt pod „dyplomację szczepionkową”
Chiny przygotowują grunt pod „dyplomację szczepionkową”

photo. Liu Bin / / Forum

PRC authorities promise some countries priority access to Chinese-developed vaccines against Covid-19 or offer loans to buy desired doses. Some commentators see this as the beginning of Beijing’s “vaccine diplomacy”.

No vaccine against the coronavirus has yet been approved for use by the World Health Organization (WHO), but governments are already striving for early doses for their citizens. Rich countries in the West either invest in research or contract vaccines with manufacturers, but poorer countries cannot afford it.

According to WHO, four out of eight of potential vaccines that have entered the final, third phase of human clinical trials are specifics developed by Chinese companies. PRC leader Xi Jinping has promised the Chinese vaccine will be a “global public good,” but it is unclear what exactly is behind this statement.

Experts at global health issues expect China, Russia and other countries to try to capitalize on the strong demand and turn any effective vaccine into a diplomatic tool, claims the US Wall Street Journal.

President of the Philippines Rodrigo Duterte revealed in late July that he had asked Xi for quick access to a Chinese vaccine when it was ready. The next day, the Chinese Foreign Ministry announced that the Philippines – “China’s friendly, close neighbor” – would get the priority they asked for.

Beijing is seeking support from the Association of Nations Southeast Asia (ASEAN) in connection with the growing conflict with the United States, which is more and more often referred to as the “new cold war”. The frictions include the South China Sea, where China has territorial disputes with several countries in the region, including the Philippines.

However, the Chinese authorities are also trying to “vaccine diplomacy” in regions considered to be the “backyard” of the United States. Chinese Foreign Minister Wang Yi recently promised Latin America and the Caribbean a $ 1 billion loan to purchase a vaccine against Covid-19, the Mexican government reported.

United States are the most affected country in the world, and US Health Minister Alex Azar announced that they would only share the vaccine with other countries after their own needs were met. By contrast, according to official figures, China has practically mastered the pandemic at home, so it is more free to offer the vaccine to others.

Helping poorer countries gain access to vaccines may improve China’s international position and strengthen its “soft power” – assessed Yanzhong Huang, global health protection specialist from the American think tank Council on Foreign Relations (CFR), quoted by the South China Morning Post.

Earlier in the Covid-19 pandemic, China donated masks and other protective equipment to other countries. This was accompanied by an aggressive public diplomacy campaign that aroused considerable controversy in the West. Critics referred to it as “masked diplomacy” and assessed that it was intended to distract attention from the mistakes made by Chinese authorities in the initial phase of the crisis.

However, meeting the demand for Vaccines in the initial period will be much more difficult than protective masks. “It will be a different level. That’s why vaccine nationalism is starting to take its toll, “said CFR Global Health Program Director Thomas J. Bollyky, quoted by WSJ.

Some commentators believe that that China must first of all produce a proven vaccine and provide it to 1.4 billion of its citizens. If they want to play a role in global supply as well, they must significantly increase their production capacity.

Another possibility is technology transfer that would allow other countries to produce vaccines developed in China . According to the media, Chinese companies have held talks about such a solution, including with companies in Brazil and Indonesia. One of the reasons is the difficulty in researching potential vaccines in China, where very few new infections have been reported recently.

The problem, however, may be the lack of confidence in the Chinese sector pharmaceuticals, notes the SCMP. In recent years, China has been shaken by several vaccine safety scandals, including drugs used to vaccinate children. Last year, the regulations in the industry were tightened last year.

From Canton Andrzej Borowiak

Source: PAP
Otwórz konto w mBanku i zgarnij do 300 zł

Open an account at mBank and get up to PLN 300

Linked : China




Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Ethereum Gas Fees Are Currently 62% Cheaper Than Last Month thumbnail

Ethereum Gas Fees Are Currently 62% Cheaper Than Last Month

Since November 9, 2021, or 46 days ago, transaction fees on the Ethereum network have been cut by more than half the rate they were on that day. At the time, the average fee to move ethereum was $62.84 per transfer and since then, the fees have dropped 62.85% to $23.34 per transaction. From $62…
Read More
Will China’s digital yuan unseat the US dollar? thumbnail

Will China’s digital yuan unseat the US dollar?

Regular CoinGeek readers will have already read some of our extensive coverage of the digital yuan. The People’s Bank of China (PBoC) has beaten every other economically powerful nation to the punch in developing a central bank digital currency (CBDC), and it looks like it’s positioning it to be a USD challenger. Right now, the e-CNY…
Read More
ProShares solicits SEC approval for Metaverse ETF thumbnail

ProShares solicits SEC approval for Metaverse ETF

You are here: Home / News / ProShares solicits SEC approval for Metaverse ETF December 30, 2021 by Aishwarya shashikumar After its successful Bitcoin ETF launch in the USA, ProShares now files with the Securities and Exchange Commission (SEC) seeking approval for the launch of Metaverse ETF. Just a few months ago, back in October,…
Read More
The 5 contech trends that will power jobsites in 2022 thumbnail

The 5 contech trends that will power jobsites in 2022

The construction industry had a challenging but positive year in 2021, and the growth of construction technology has been one of the bright spots. With the pandemic forcing faster adoption of technological tools, experts and investors are recognizing the sector's increasing importance. The federal government is also providing an assist, with $100 million designated for contech in…
Read More
בתוך חודשיים -500 מיליון שקל thumbnail

בתוך חודשיים -500 מיליון שקל

שוק ההון חברת ההנדסה זכתה בחוזה להקמת שני מפעלים בתחום התעשייה התהליכית באסיה בהיקף של 220 מיליון שקל ובשותפות עם קבלן משנה ישראלי הינך עוקב בהצלחה אחרי יורם גביזון. ניתן לראות עדכונים על כתבות חדשות בעמוד הארץ שלי מאיר דור, יו"ר ברןאייל טואג מניית חברת ברן קופצת ב-4.7% ומשלימה עלייה של 23% מתחילת 2022, לאחר…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?